Anti-restenosis agent
AssigneesCube Medical A/S, Centre National De La Recherche Scientifique
InventorsErik Anderson, Trung Le Doan, Laurent Lamidey
Life of this patent
Estimating the term…
Abstract
An anti-restenosis agent comprises a phosphorothioate-modified oligonucleotide includes at least on hairpin loop and a TG sequence. The hairpin loop preferably has the sequence CAG CGA AGC. Especially preferred oligonucleotides are ones which include a sequence selected from TGGGG TGGGG T GGGGT GGGGT CAG CGA AGC (SEQ ED NO: 4) and TTGGG TTGGG T GGGTT GGGTT CAG CGA AGC (SEQ TD NO: 6). The anti-restenosis agent may be used as or in a coating on a device for implantation into the body, for instance a stent.
Claims20
An anti-restenosis agent comprising a phosphorothioate-modified oligonucleotide, wherein the oligonucleotide includes at least one hairpin loop and a dT or dG releasing group (TG).
Dependencies are inferred from the claim text.